Skip to content

Effectiveness of a Cognitive Training Program (UMAM Method) in Elderly People Without Dementia

Cognitive Training in Elders Without Dementia Using UMAM Method. Genetic, Brain Volume and Cognitive Reserve Predictors: A Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04245579
Enrollment
199
Registered
2020-01-29
Start date
2013-10-31
Completion date
2015-05-31
Last updated
2020-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-Related Memory Disorders

Keywords

cognitive training, memory failures, APOE, brain volume, cognitive reserve

Brief summary

The study is oriented to analyze the effectiveness of a cognitive training method (UMAM) on cognitive functions, subjective memory and mood state in elderly people without dementia. On the other hand, the study aims to examine whether variables such as cognitive reserve (e.g. educational level), APOE genotype and intracranial volume are related to increased benefit after the intervention. The researchers hope to find that greater cognitive reserve, not having the APOE allele ε4, and a greater volume of memory-related brain areas, are associated with better outcomes after the cognitive intervention.

Interventions

OTHERMultifactorial Memory Training Program (UMAM method)

Sponsors

Universidad Complutense de Madrid
CollaboratorOTHER
Hospital San Carlos, Madrid
CollaboratorOTHER
Centro de Tecnología Biomédica, Madrid
CollaboratorUNKNOWN
Madrid Salud
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Being over 60 years old. * Having a global cognitive performance \> 23 in the Mini Mental State Examination Test. * Having no history of neurological or serious psychiatric disorders (severe psycho-affective disorders and psychosis or other psychiatric disorders like alcoholism).

Exclusion criteria

* Chronic use of anxiolytics. * Chronic use of neuroleptics. * Chronic use of anticonvulsants. * Having hearing or vision impairments that would preclude testing. * Magnetic Resonance Imaging (MRI) contraindications.

Design outcomes

Primary

MeasureTime frameDescription
The Cognitive Reserve as a predictor of change.Cognitive Reserve was assessed in the pre-intervention assessment.The Cognitive Reserve was assessed with Rami Test. The score ranges from 0 to 25 points.
Change in general cognitionThis cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in general cognition, assessed with the Mini Mental State Examination Test (MMSE) and the 7 Minutes Test (7M).The score ranges from 0 to 30 points (MMSE) and from 0 to 89 points (7M). In both cases, the higher scores indicate a better outcome.
Change in verbal memoryThis cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in verbal memory, assessed with the Word List Test of the Wechsler Memory Scale-III. The score ranges from 0 to 48 points. Higher scores indicate a better outcome.
Change in logical memoryThis cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in immediate and delayed logical memory, assessed with the Logical Memory Test (immediate and delayed units) of the Wechsler Memory Scale-III. The score ranges from 0 to 75 points (immediate units) and from 0 to 50 (delayed units). Higher scores indicate a better outcome.
Change in visual memoryThis cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in visual memory, assessed with the Rey memory test (form B). The score ranges from 0 to 22 points. Higher scores indicate a better outcome.
Change in daily memoryThis cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in daily memory, assessed with the Rivermead Behavioral Memory Test. The score ranges from 0 to 24 points. Higher scores indicate a better outcome.
Change in attentional amplitudeThis cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in attentional amplitude, assessed with the Direct Digit Test of the Wechsler Memory Scale-III. The score ranges from 0 to 16 points. Higher scores indicate a better outcome.
Change in attentional controlThis cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in attentional control, assessed with the Inverse Digit Test of the Wechsler Memory Scale-III. The score ranges from 0 to 14 points. Higher scores indicate a better outcome.
Change in attention and processing speedThis cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in attention, assessed with the Trail Making Test, form A. The score ranges from 0 to 200 points. Higher scores indicate a worse outcome.
Change in alternating attention and planningThis cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in alternating attention and planning, assessed with the Trail Making Test, form B. The score ranges from 0 to 400 points. Higher scores indicate a worse outcome.
Change in naming ability (language)This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in naming ability, assessed with the Boston Naming Test. The score ranges from 0 to 60 points. Higher scores indicate a better outcome.
Change in verbal fluency (language)This cognitive variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in phonologic and semantic verbal fluency, assessed with the Phonological Verbal Fluency Test and the Semantic Fluency Test respectively. The score goes from zero onwards (there is no upper limit). Higher scores indicate a better outcome.
Change in subjective memoryThis variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in Subjective Memory, assessed with the Memory Failures of Everyday Questionnaire.The score ranges from 0 to 56 points. Higher scores indicate a worse outcome.
Change in moodThis variable was assessed before and after the intervention. The interval between the pre and post-intervention assessment was 6 months.The measure of the post-intervention change in mood, assessed with the Geriatric Depression Scale. The score ranges from 0 to 15 points. Higher scores indicate a worse outcome.
The Genetic Profile as a predictor of change.The Genetic Profile was assessed in the pre-intervention assessment.The Genetic Profile was obtained by genetic analysis employing a blood test. APOE gene has been coded as 1 (meaning no ε4 allele), or 0 (for at least one ε4 allele).
The Brain Volume as a predictor of change.The Brain Volume was assessed in the pre-intervention assessment.The Brain Volume (total gray volume, left hippocampus, right hippocampus and total intracranial volume) was assessed by magnetic resonance imaging. Unit of measure: mm3.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026